Lipids and liposomes in the enhancement of health and treatment of disease

TKS research is supported in part by the Wellcome Trust, SUSLA, BBSRC and the European Community’s Seventh Framework Programme under grant agreement No.602773 (Project KINDReD).

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-06-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.5772/59665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Discovery and Development - From Molecules to Medicine

  2015cited by this paper
• In Vitro Combination of Voriconazole and Miltefosine against Clinically Relevant Molds

  2014cited by this paper
• Structural elucidation of olive pomace fed sea bass (Dicentrarchus labrax) polar lipids with cardioprotective activities.

  2014cited by this paper
• Liposomes as delivery systems for carotenoids: comparative studies of loading ability, storage stability and in vitro release.

  2014cited by this paper
• Liposomal siRNA nanocarriers for cancer therapy.

  2014cited by this paper
• Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms

  2014cited by this paper
• Designer lipids for drug delivery: from heads to tails.

  2014cited by this paper
• Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study.

  2014cited by this paper
• Anticancer mechanisms and clinical application of alkylphospholipids.

  2013cited by this paper
• Chemical Tools for Studying the Biological Function of Glycolipids

  2013cited by this paper
• Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease.

  2013cited by this paper
• Synthesis and antifungal activities of miltefosine analogs.

  2013cited by this paper
• Sialylneolacto-N-tetraose c (LSTc)-bearing Liposomal Decoys Capture Influenza A Virus*

  2013cited by this paper
• Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B

  2013cited by this paper
• Delivery materials for siRNA therapeutics.

  2013cited by this paper
• Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism

  2013cited by this paper
• Bioavailability of Polyphenol Liposomes: A Challenge Ahead

  2013cited by this paper
• Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model

  2013cited by this paper
• Health effects of dietary phospholipids

  2012cited by this paper
• Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

  2012cited by this paper
• Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated Cryptococcosis

  2012cited by this paper
• Marine Omega-3 Phospholipids: Metabolism and Biological Activities

  2012cited by this paper
• Extended pain relief trial utilizing infiltration of Exparel®, a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomy

  2012cited by this paper
• Altering the immune response with lipid-based nanoparticles.

  2012cited by this paper
• Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India

  2012cited by this paper
• Nucleoside-lipid-based nanoparticles for cisplatin delivery.

  2011cited by this paper
• Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy

  2011cited by this paper
• A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

  2011cited by this paper
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.

  2011cited by this paper
• Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.

  2011cited by this paper
• First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

  2011cited by this paper
• Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.

  2011cited by this paper
• Miltefosine Induces Apoptosis-Like Cell Death in Yeast via Cox9p in Cytochrome c Oxidase

  2011cited by this paper
• Lipid mediators in life science.

  2011cited by this paper
• Antiobesity mechanisms of action of conjugated linoleic acid.

  2010cited by this paper
• Dietary Phospholipids and Intestinal Cholesterol Absorption

  2010cited by this paper
• Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis

  2010cited by this paper
• Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma

  2010cited by this paper
• Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.

  2009cited by this paper
• Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study.

  2009cited by this paper
• Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.

  2009cited by this paper
• In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.

  2009cited by this paper
• Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

  2009cited by this paper
• Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery.

  2009cited by this paper
• Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane properties.

  2008cited by this paper
• Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease

  2008cited by this paper
• Epaxal®: a virosomal vaccine to prevent hepatitis A infection

  2008cited by this paper
• Cationic liposomal lipids: from gene carriers to cell signaling.

  2008cited by this paper
• Preparation of Alendronate Liposomes for Enhanced Stability and Bioactivity: In Vitro and In Vivo Characterization

  2008cited by this paper
• Stabilization of ascorbic acid by microencapsulation in liposomes

  2007cited by this paper
• Protective Effect of Coenzyme Q10-loaded Liposomes on the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction

  2007cited by this paper
• The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro

  2006cited by this paper
• Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis

  2006cited by this paper
• Particulate systems as adjuvants and carriers for peptide and protein antigens.

  2006cited by this paper
• n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.

  2006cited by this paper
• Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

  2006cited by this paper
• MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle

  2005cited by this paper
• Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency

  2005cited by this paper
• Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid

  2005cited by this paper
• The diffusion of ions from a phospholipid model membrane system

  2005cited by this paper
• A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

  2005cited by this paper
• Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.

  2005cited by this paper
• ATP-Loaded Liposomes Effectively Protect the Myocardium in Rabbits with an Acute Experimental Myocardial Infarction

  2005cited by this paper
• Applications of liposomes in ophthalmology.

  2005cited by this paper
• ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model.

  2005cited by this paper
• Current methods for attaching targeting ligands to liposomes and nanoparticles.

  2004cited by this paper
• Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono-and combinationchemotherapy

  2004cited by this paper
• Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression.

  2004cited by this paper
• Extended-release formulation of morphine for subcutaneous administration

  2004cited by this paper
• Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.

  2004cited by this paper
• Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.

  2004cited by this paper
• Miltefosine (Impavido): the first oral treatment against leishmaniasis

  2004cited by this paper
• Physical and chemical evaluation of liposomes, containing artesunate.

  2003cited by this paper
• Antiprotozoal activities of phospholipid analogues.

  2003cited by this paper
• Combination with an antisense oligonucleotide synergistically improves the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium in chronic myeloid leukemia cell lines.

  2002cited by this paper
• Drug delivery system of anti-fungal and parasitic agents.

  2002cited by this paper
• Coenzyme Q10 and cardiovascular disease: a review.

  2002cited by this paper
• Liposomes in nutrition

  2001cited by this paper
• Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.

  2001cited by this paper
• Polyunsaturated fatty acids, inflammation, and immunity

  2001cited by this paper
• Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.

  2001cited by this paper
• Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes.

  2000cited by this paper
• Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

  2000cited by this paper
• Apoptosis is initiated by myocardial ischemia and executed during reperfusion.

  2000cited by this paper
• Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes

  2000cited by this paper
• In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.

  1999cited by this paper
• Encapsulation in the food industry: a review.

  1999cited by this paper
• Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

  1999cited by this paper
• Oral treatment of visceral leishmaniasis with miltefosine.

  1999cited by this paper
• Double‐blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema

  1999cited by this paper
• U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.

  1999cited by this paper
• In vivo evaluation of arteether liposomes

  1998cited by this paper
• Novel applications of liposomes.

  1998cited by this paper
• Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.

  1998cited by this paper
• Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.

  1998cited by this paper
• Liposomes in drug delivery: Progress and limitations

  1997cited by this paper
• D-21266, a new heterocyclic alkylphospholipid with antitumour activity.

  1997cited by this paper
• Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.

  1997cited by this paper
• The exogenous surfactant Curosurf enhances phosphatidylcholine content in isolated type II cells.

  1997cited by this paper
• A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?

  1996cited by this paper

• Nanoscale chemical imaging of individual chemotherapeutic cytarabine-loaded liposomal nanocarriers

  2018cites this paper